Top Wall Street Forecasters Revamp Pfizer Expectations Ahead Of Q3 Earnings
Pfizer will report Q3 earnings Nov. 3; analysts expect EPS to fall to $0.73 and revenue to $15.88B, while recent ratings remain mixed.
Share
Why It Matters
Smart money watchers are changing their guesses about Pfizer before earnings. They think the company will make less money than before.
This read is generated by AI from raw market data and is for education only. It is not financial advice, not a signal, and not a recommendation to buy or sell.
Tickers in Play
Last session drawn · prints held ~15 minutes · licensed exchange data
Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.
Disclosure: Educational and informational purposes only. Not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.